Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Nurix Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 211
- +17 vs. Q1 2026
- Shares held
- 117.3M
- +250.4K (+0.2%) vs. Q1 2026
- Total value
- $2.84B
- +$1.03B (+56.8%) vs. Q1 2026
- New holders
- 46
- 66 more added
- Sold out
- 29
- 64 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 4,320,422 | $104.8M | 1.63% | +609,545+16.4% | Added |
| Vanguard Capital Management LLC | 4,495,529 | $109.1M | 0.00% | +68,417+1.5% | Added |
| Baker Bros. Advisors LP | 4,658,556 | $113.0M | 0.57% | 00.0% | Unchanged |
| State Street Corp | 4,677,244 | $113.5M | 0.00% | −463,951−9.0% | Reduced |
| Morgan Stanley | 4,762,484 | $115.5M | 0.01% | −169,515−3.4% | Reduced |
| Price T Rowe Associates Inc | 5,436,587 | $131.9M | 0.01% | +2,146,354+65.2% | Added |
| FMR LLC | 5,485,215 | $133.1M | 0.01% | −56,056−1.0% | Reduced |
| Rubric Capital Management LP | 7,227,778 | $175.3M | 1.61% | +4,753,893+192.2% | Added |
| Deep Track Capital, LP | 7,736,455 | $187.7M | 2.76% | +1,391,211+21.9% | Added |
| Vestal Point Capital, LP | 8,050,000 | $195.3M | 4.56% | +1,550,000+23.8% | Added |
| BlackRock, Inc. | 8,770,349 | $212.8M | 0.00% | −155,293−1.7% | Reduced |
| Commodore Capital LP | 0 | $0 | 0.00% | −2,275,000−100.0% | Sold out |
| Longaeva Partners L.P. | 0 | $0 | 0.00% | −1,490,202−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −315,226−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −224,535−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −118,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −62,503−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −61,825−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −51,347−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −45,171−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −44,976−100.0% | Sold out |
| Massachusetts Financial Services Co | 0 | $0 | 0.00% | −42,603−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −27,150−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −26,501−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −20,145−100.0% | Sold out |
| AlphaGrep UK Ltd | 0 | $0 | 0.00% | −19,096−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −14,489−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,256−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,273−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,553−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −10,018−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,113−100.0% | Sold out |
| Cygnus Capital Advisors, LLC | 0 | $0 | 0.00% | −3,300−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −779−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |